Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Argininosuccinate synthetase 1 pseudogene 6 (ASS1P6) is classified as a pseudogene and does not encode a functional protein product. Pseudogenes are gene sequences that resemble functional genes but are typically non-coding due to mutations or lack of regulatory elements. ASS1P6 is related by sequence similarity to the protein-coding gene argininosuccinate synthetase 1 (ASS1), which plays a key role in the urea cycle and arginine biosynthesis, but ASS1P6 itself does not perform these enzymatic or receptor functions[5]. ASS1P6 is specifically described in genetic databases as a pseudogene, lacking protein-coding function and not associated with canonical molecular targets such as enzymes, receptors, or transporters[5]. Its nomenclature and aliases reflect its origin as a nonfunctional duplicate or processed fragment of the functional ASS1 gene[5]. There is no evidence or literature to support a therapeutic, diagnostic, or biomarker role for ASS1P6. ASS1P6 is not listed as a disease gene, is not targeted by drugs, and has no described mechanism of action, safety profile, or biological/pathophysiological function. This pseudogene should not be confused with argininosuccinate synthase 1 (ASS1), which is a validated therapeutic and biomarker target. No spelling or information errors were found with the designation of ASS1P6, but its lack of function means it is outside the scope of therapeutic target research[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate synthetase 1 pseudogene 6 (ASS1P6).